Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Reloxan
- Development stage
- Unknown
- Lead developer
- Schwabe
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Reloxan is an over-the-counter medical device marketed by Schwabe for the rapid and sustained relief of heartburn, acid regurgitation, and acid-related stomach discomfort. It is formulated as a chewable tablet containing a combination of mineral antacids (calcium carbonate and magnesium carbonate) and a highly concentrated plant-based protective substance (prickly pear cactus extract, *Opuntia ficus-indica*). The mineral components quickly neutralize excess stomach acid, while the polysaccharides from the prickly pear extract form a soothing, mucoadhesive protective film over the irritated esophageal and gastric mucosa to prevent further irritation.
- Brand names
- ReloxanReloxan FruitReloxan MintReloxan Passionsfrucht
- Other names
- calcium carbonate + magnesium carbonate + prickly pear extract
Beyond the preview
Go deeper on Reloxan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reloxan.